Literature DB >> 31471762

World Cancer Research Fund International: Continuous Update Project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk.

Doris S M Chan1, Leila Abar2, Margarita Cariolou2, Neesha Nanu2, Darren C Greenwood3, Elisa V Bandera4, Anne McTiernan5, Teresa Norat2.   

Abstract

PURPOSE: The purpose of the present study was to systematically review the complex associations between energy balance-related factors and breast cancer risk, for which previous evidence has suggested different associations in the life course of women and by hormone receptor (HR) status of the tumor.
METHODS: Relevant publications on adulthood physical activity, sedentary behavior, body mass index (BMI), waist and hip circumferences, waist-to-hip ratio, and weight change and pre- and postmenopausal breast cancer risk were identified in PubMed up to 30 April 2017. Random-effects meta-analyses were conducted to summarize the relative risks across studies.
RESULTS: One hundred and twenty-six observational cohort studies comprising over 22,900 premenopausal and 103,000 postmenopausal breast cancer cases were meta-analyzed. Higher physical activity was inversely associated with both pre- and postmenopausal breast cancers, whereas increased sitting time was positively associated with postmenopausal breast cancer. Although higher early adult BMI (ages 18-30 years) was inversely associated with pre- and postmenopausal breast cancers, adult weight gain and greater body adiposity increased breast cancer risk in postmenopausal women, and the increased risk was evident for HR+ but not HR- breast cancers, and among never but not current users of postmenopausal hormones. The evidence was less consistent in premenopausal women. There were no associations with adult weight gain, inverse associations with adult BMI (study baseline) and hip circumference, and non-significant associations with waist circumference and waist-to-hip ratio that were reverted to positive associations on average in studies accounting for BMI. No significant associations were observed for HR-defined premenopausal breast cancers.
CONCLUSION: Better understanding on the impact of these factors on pre- and postmenopausal breast cancers and their subtypes along the life course is needed.

Entities:  

Keywords:  Adiposity; Breast cancer; Life course; Physical activity; Systematic literature review; Weight change

Mesh:

Year:  2019        PMID: 31471762     DOI: 10.1007/s10552-019-01223-w

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

Review 1.  Metabolic pathways in obesity-related breast cancer.

Authors:  Kristy A Brown
Journal:  Nat Rev Endocrinol       Date:  2021-04-29       Impact factor: 43.330

2.  A pooled case-only analysis of obesity and breast cancer subtype among Black women in the southeastern United States.

Authors:  Maureen Sanderson; Loren Lipworth; Jaleesa Moore; Tuya Pal; Alicia Beeghly-Fadiel; Mary Kay Fadden; Heather M Munro; Steffie-Ann Dujon; Sonya Reid; Ann Tezak; Miaya Blasingame; Jeania Ware; William J Blot; Xiao-Ou Shu; Wei Zheng
Journal:  Cancer Causes Control       Date:  2022-01-28       Impact factor: 2.506

3.  RAB27A and RAB27B Expression May Predict Lymph Node Metastasis and Survival in Patients With Gastric Cancer.

Authors:  Hyo Jung An; Jong Sil Lee; Jung Wook Yang; Min Hye Kim; Ji Min Na; Dae Hyun Song
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

4.  Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.

Authors:  Maria Alice Franzoi; Daniel Eiger; Lieveke Ameye; Noam Ponde; Rafael Caparica; Claudia De Angelis; Mariana Brandão; Christine Desmedt; Serena Di Cosimo; Nuria Kotecki; Matteo Lambertini; Ahmad Awada; Martine Piccart; Evandro de Azambuja
Journal:  J Natl Cancer Inst       Date:  2021-04-06       Impact factor: 13.506

5.  Fragmentation of Care Among Black Women With Breast Cancer and Comorbidities: The Role of Health Systems.

Authors:  Michelle Doose; Janeth I Sanchez; Joel C Cantor; Jesse J Plascak; Michael B Steinberg; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera; Jennifer Tsui
Journal:  JCO Oncol Pract       Date:  2021-05

6.  Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status.

Authors:  Michael C S Bissell; Karla Kerlikowske; Brian L Sprague; Jeffery A Tice; Charlotte C Gard; Katherine Y Tossas; Garth H Rauscher; Amy Trentham-Dietz; Louise M Henderson; Tracy Onega; Theresa H M Keegan; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

7.  Association of Body Mass Index, Central Obesity, and Body Composition With Mortality Among Black Breast Cancer Survivors.

Authors:  Elisa V Bandera; Bo Qin; Yong Lin; Nur Zeinomar; Baichen Xu; Dhanya Chanumolu; Adana A M Llanos; Coral O Omene; Karen S Pawlish; Christine B Ambrosone; Kitaw Demissie; Chi-Chen Hong
Journal:  JAMA Oncol       Date:  2021-06-04       Impact factor: 33.006

Review 8.  Cancer Progress and Priorities: Breast Cancer.

Authors:  Serena C Houghton; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05       Impact factor: 4.090

9.  Risk factors for breast cancer subtypes among Black women undergoing screening mammography.

Authors:  Tara M Friebel-Klingner; Sarah Ehsan; Emily F Conant; Despina Kontos; Susan M Domchek; Anne Marie McCarthy
Journal:  Breast Cancer Res Treat       Date:  2021-08-03       Impact factor: 4.872

10.  Dose-response effects of aerobic exercise on adiposity markers in postmenopausal women: pooled analyses from two randomized controlled trials.

Authors:  Paola Gonzalo-Encabo; Jessica McNeil; Alberto Pérez-López; David Valadés; Kerry S Courneya; Christine M Friedenreich
Journal:  Int J Obes (Lond)       Date:  2021-03-16       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.